Rajesh Krishnan
Chief Tech/Sci/R&D Officer presso ONCTERNAL THERAPEUTICS, INC.
Patrimonio netto: 19 809 $ in data 31/03/2024
Profilo
Rajesh Krishnan is currently the Chief Technology Officer at Oncternal Therapeutics, Inc. Prior to his current position, he held the role of Head-Biologics Drug Substance Process Development at Gilead Sciences, Inc. from 2012 to 2017.
He also served as the VP-Process Development & Manufacturing Sciences at Dynavax Technologies Corp.
from 2018 to 2019.
Dr. Krishnan completed his undergraduate degree at Princeton University and holds graduate and doctorate degrees from the University of California, Davis.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 14/02/2024 | 2 201 ( 0.07% ) | 19 809 $ | 31/03/2024 |
Posizioni attive di Rajesh Krishnan
| Società | Posizione | Inizio |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Rajesh Krishnan
| Società | Posizione | Fine |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01/01/2019 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2017 |
Formazione di Rajesh Krishnan
| Princeton University | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
- Borsa valori
- Insiders
- Rajesh Krishnan
